Dehong Yan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Radiation Therapy

Squamous Cell Carcinoma

Top Venues

Clinical & translational immunology

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Qian Wu, Jin Li, Pei Wang, Qihang Peng, Zhongcui Kang, Yiting Deng, Jiayi Li, Dehong Yan, Feng Ge, Ying Chen
FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with m 6 A Modification and Necroptosis. Genes 14 (3) (2023)
Qian Wu, Jin Li, Pei Wang, Qihang Peng, Zhongcui Kang, Yiting Deng, Jiayi Li, Dehong Yan, Feng Ge, Ying Chen
FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with m 6 A Modification and Necroptosis. Genes 14 (3) (2023)
Qian Wu, Jin Li, Pei Wang, Qihang Peng, Zhongcui Kang, Yiting Deng, Jiayi Li, Dehong Yan, Feng Ge, Ying Chen
FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with m 6 A Modification and Necroptosis. Genes 14 (3) (2023)
Mengqi Zhang, Lulu Wang, Wan Liu, Tian Wang, Francesco De Sanctis, Lifang Zhu, Guizhong Zhang, Jian Cheng, Qin Cao, Jingying Zhou, Aldo Tagliabue, Vincenzo Bronte, Dehong Yan, Xianchun Wan, Guang Yu
Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors. Journal of immunology research 2022 (2022)
Lukman O Afolabi, Mariam O Afolabi, Musbahu M Sani, Wahab O Okunowo, Dehong Yan, Liang Chen, Yaou Zhang, Xiaochun Wan
Exploiting the CRISPR-Cas9 gene-editing system for human cancers and immunotherapy. Clinical & translational immunology 10 (6) (2021)